Harrison--39-s Gastroenterology And Hepatology- 3rd Edition -

Non-alcoholic steatohepatitis (NASH) is now a leading cause of cirrhosis and liver transplantation. The 3rd edition incorporates the latest diagnostic biomarkers (e.g., FIB-4, ELF test) and management strategies, including lifestyle interventions and emerging pharmacotherapies like resmetirom (the first FDA-approved agent for NASH with fibrosis). For viral hepatitis, updated guidance on hepatitis B cure strategies and hepatitis C DAA (direct-acting antiviral) retreatment for non-responders is included.

: Coverage of capsule endoscopy, MRI, and molecular diagnostics. Harrison--39-s Gastroenterology And Hepatology- 3rd Edition

If you were looking for this information for a specific purpose, here is how you might categorize it: Non-alcoholic steatohepatitis (NASH) is now a leading cause

Harrison S Gastroenterology And Hepatology 3rd Ed - mchip.net ELF test) and management strategies